Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to $1.3 million.

  • Cannabis Bioscience International Holdings' Total Liabilities rose 1484.87% to $1.3 million in Q3 2025 from the same period last year, while for Aug 2025 it was $1.3 million, marking a year-over-year increase of 1484.87%. This contributed to the annual value of $1.2 million for FY2025, which is 521.82% up from last year.
  • Cannabis Bioscience International Holdings' Total Liabilities amounted to $1.3 million in Q3 2025, which was up 1484.87% from $1.2 million recorded in Q2 2025.
  • Cannabis Bioscience International Holdings' 5-year Total Liabilities high stood at $1.3 million for Q3 2025, and its period low was $405301.0 during Q4 2022.
  • Moreover, its 4-year median value for Total Liabilities was $1.1 million (2024), whereas its average is $949310.7.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 13284.57% in 2023, then surged by 521.82% in 2025.
  • Quarter analysis of 4 years shows Cannabis Bioscience International Holdings' Total Liabilities stood at $405301.0 in 2022, then soared by 132.85% to $943726.0 in 2023, then rose by 27.11% to $1.2 million in 2024, then increased by 5.47% to $1.3 million in 2025.
  • Its Total Liabilities stands at $1.3 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.2 million for Q1 2025.